Maria Alsina-Maqueda
Pamplona, NC 31008, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Insights into ctDNA assessment to detect minimal residual disease (MRD) in localized colorectal cancer.
Journal: Scientific reports
Published: March 23, 2026
Correction: Biomarkers in gastroesophageal cancer 2025: an updated consensus statement by the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP).
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: June 28, 2025
Biomarkers in gastroesophageal cancer 2025: an updated consensus statement by the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP).
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: January 24, 2025
Correction: the TEOGIC study project: a comprehensive characterization of early onset gastrointestinal cancer in the Northern area of Spain.
Journal: BMC cancer
Published: July 09, 2024
Immune checkpoint inhibitors for first-line treatment of advanced esophageal squamous cell carcinoma.
Journal: Med (New York, N.Y.)
Published: May 29, 2024
The TEOGIC study project: a comprehensive characterization of early onset gastrointestinal cancer in the Northern area of Spain.
Journal: BMC cancer
Published: February 12, 2024
Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform.
Journal: The oncologist
Published: November 30, 2022
Immunotherapy in gastrointestinal cancer: Recent results, current studies and future perspectives.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 15, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026